✦ LIBER ✦

The REPLACE 1 trial: a pilot study of bivalirudin versus heparin during percutaneous coronary intervention with stenting and GP IIb/IIIa blockade

✍ Scribed by A.Michael Lincoff; John A. Bittl; Neal S. Kleiman; Dean J. Kereiakes; Robert A. Harrington; Ian J. Sarembock; J.Daniel Jackman; Sameer Mehta; Elizabeth F. Maierson; Derek P. Chew; Eric J. Topol

Book ID: 119543629
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 336 KB
Volume: 39
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(02)80069-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic evaluation of bivalirudin with

Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: Results from the REPLACE-2 trial

✍ David J. Cohen; A. Michael Lincoff; Tara A. Lavelle; Huei-Ling Chen; Ameet Bakha 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Bivalirudin versus heparin and glycoprot

Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial)

✍ Derek P. Chew; A. Michael Lincoff; Hitinder Gurm; Katherine Wolski; David J. Coh 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Provisional glycoprotein IIb/IIIa blocka

Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial

✍ J. Emilio Exaire; Samuel M. Butman; Ramin Ebrahimi; Neal S. Kleiman; Robert A. H 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Comparison of bivalirudin versus heparin

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

✍ A.Michael Lincoff; John A Bittl; Neal S Kleiman; Ian J Sarembock; J.Daniel Jackm 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 107 KB

711-3-A Multicenter, Randomized, Double-

711-3-A Multicenter, Randomized, Double-Blind Pilot Trial of Standard Versus Low Dose Weight-Adjusted Heparin in Patients Treated with the Platelet GP IIb/IIIa Receptor Antibody c7E3 During Percutaneous Coronary Revascularization

✍ A. Michael Lincoff; James E. Tcheng; Theodore A. Bass; Jeffrey J. Popma; Paul S. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Safety and Efficacy of Bivalirudin With

Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

✍ Harvey D. White; E. Magnus Ohman; A. Michael Lincoff; Michel E. Bertrand; Antoni 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 571 KB